Increasing access to harm reduction services through mail delivery in the U.S.
Expansion of Mail-Delivered Harm Reduction Services in the U.S.
This study is looking to make it easier for people to get important harm reduction supplies, like syringes and naloxone, by exploring how mail delivery can help, and it’s for anyone who might need these resources to stay safe and healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10590378 on NIH RePORTER |
What this research studies
This research aims to improve access to harm reduction services, such as syringes and naloxone, by expanding mail delivery options. It will investigate the legal barriers to distributing these services across the U.S. and conduct a national study to understand how individuals engage with mail-based harm reduction. By surveying stakeholders and potential users, the project seeks to identify preferences and challenges in accessing these critical health resources. The goal is to create a more convenient and confidential way for individuals to obtain harm reduction supplies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who use injectable drugs or are at risk of opioid overdose and are seeking harm reduction services.
Not a fit: Patients who do not use injectable drugs or are not at risk of opioid overdose may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce overdose deaths and prevent the spread of HIV and hepatitis C among at-risk populations.
How similar studies have performed: Previous research has shown that mail-based harm reduction services can effectively increase access to essential health supplies, indicating a promising approach.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Behrends, Czarina Navos — Weill Medical Coll of Cornell Univ
- Study coordinator: Behrends, Czarina Navos
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.